BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 9013200)

  • 1. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
    Chang MC; Chang HH; Wang TM; Chan CP; Lin BR; Yeung SY; Yeh CY; Cheng RH; Jeng JH
    PLoS One; 2014; 9(8):e104310. PubMed ID: 25122505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of the new anti-platelet agent KBT-3022 and its metabolite on rabbit neutrophil function in vitro.
    Yokota K; Yamamoto N; Obata Y; Oda M
    Jpn J Pharmacol; 1996 Apr; 70(4):291-302. PubMed ID: 8847836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022.
    Shimazawa M; Takiguchi Y; Umemura K; Kondo K; Nakashima M
    Eur J Pharmacol; 1997 Jun; 328(2-3):183-9. PubMed ID: 9218700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of KBT-3022, a new diphenylthiazole derivative, on platelet functions.
    Yokota K; Yamamoto N; Morimoto Y; Yamashita A; Oda M
    J Pharm Pharmacol; 1995 Sep; 47(9):768-74. PubMed ID: 8583391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of KBT-3022, a new cyclooxygenase inhibitor, on experimental brain edema in vitro and in vivo.
    Yamamoto N; Yokota K; Yamashita A; Oda M
    Eur J Pharmacol; 1996 Feb; 297(3):225-31. PubMed ID: 8666054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of action of KBT-3022, a new antiplatelet agent.
    Matsuo K; Yokota K; Yamashita A; Oda M
    Gen Pharmacol; 1997 Feb; 28(2):229-35. PubMed ID: 9013200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A concept for the mechanism of prostacyclin and thromboxane A2 biosynthesis.
    Ullrich V; Hecker M
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():95-101. PubMed ID: 2144703
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostacyclin and thromboxane synthases.
    Tanabe T; Ullrich V
    J Lipid Mediat Cell Signal; 1995 Oct; 12(2-3):243-55. PubMed ID: 8777569
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.